AP: Himalaya helps build jail inmates' herb farming skills Prisoners in Ananthapur in Andhra Pradesh are getting a second chance in life. Through a unique rehabilitation program started by the pharmaceutical company Himalaya, the inmates are now turning to herb farming. ...  
10:20 AM, Feb 19, 2013

Slow approvals put India's drug trials industry at risk Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to shift operations elsewhere, adding to their costs. ...  
02:20 AM, Feb 13, 2013

Saudi Arabia to allow women to work in pharmacies
by IANS
Saudi Labor Minister Adel Faqih announced on the weekend that women will soon be allowed to work in pharmacies, a job held only by men so far, media reports said. Faqih said at a private business event that his ministry was working to prepare a "safe and proper" environment that guarantees the employment of women in pharmacies. ...  
12:50 PM, Feb 04, 2013

Indian-American jailed for 17 years for healthcare fraud
by
An Indian-American pharmacist has been sentenced to 17 years in prison by a US court for a major healthcare fraud worth USD 57 million. Babubhai (Bob) Patel, 50, who owned and operated 26 pharmacies across metro Detroit, was sentenced in Michigan court, five months after a jury convicted him of billing the government for more than USD 57 million for painkillers that were medically unnecessary or never provided. ...  
02:30 PM, Feb 03, 2013

US exports may drive growth of Indian pharma companies Top Indian pharma players will continue to grow strongly at over 20 per cent in 2013, primarily led by exports to the US market, India Ratings said in its outlook for the sector. "We believe that top players of the sector will continue to grow strongly in 2013 (over 20 per cent per annum), primarily led by exports. Of the export markets, Indian pharma will focus on the US market...  
12:14 PM, Feb 03, 2013

Yusuf Hamied's message on being CNN-IBN's IOTY in business category Dr. Yusuf K Hamied of Cipla Limited was awarded the CNN-IBN Indian of The Year 2012 in the business category. He was awarded for taking on multinational pharma companies and making some of the essential drugs more affordable to the masses in the developing countries. Here's Dr Hamid's message after being awarded by CNN-IBN Honoured Guests and Friends, For the past 52 years, I have been actively involved with the...  
12:22 PM, Dec 17, 2012

More clarity on FDI in pharma sector soon: PM
by IANS
New Delhi: Prime Minister Manmohan Singh on Saturday said that the government is trying to bring greater clarity on allowing foreign capital inflows in the domestic pharma sector. "We are bringing greater clarity the FDI (foreign direct investment) policy in the pharma sector," he said in his address at the annual general meeting of the Federation of Indian Chambers of Commerce and Industry (FICCI). His statement came following the cabinet...  
01:50 AM, Dec 16, 2012

Yusuf Hamied declared Indian of the Year 2012 in business category New Delhi: Yusuf Hamied, chairman of Indian pharmaceutical giant Cipla, has won the Indian of the Year 2012 award in the business category. Hamied, who is a leading Indian scientist, created a stir in pharmaceuticals industry when he slashed the prices of three important cancer drugs by 75 per cent. Hamied was up against Chanda Kochhar of ICICI, who is the first woman to lead India's second-largest lender and N...  
09:46 PM, Dec 12, 2012

India approves policy to cap prices of 348 medicine New Delhi/Mumbai: India approved a new drug pricing policy designed to increase the number of drugs deemed essential that are subject to price caps, two ministers told reporters. The move will curtail prices of costly brands sold by domestic and international drugmakers in a market that already has rock-bottom medicine prices, meaning analysts and industry officials are sceptical about the benefits of the policy. The prices of 348 drugs deemed...  
08:11 PM, Nov 22, 2012

Cipla appoints Subhanu Saxena as new CEO Bangalore: Drug-maker Cipla on Thursday said it has appointed Subhanu Saxena as the Chief Executive Officer of the company. The appointment is effective from February 1, 2013. Saxena has more than 25 years of work experience. He has worked with companies such as Citicorp, The Boston Consulting Group and PepsiCo, across markets in Europe, North America, Africa and Asia, Cipla said in a statement. In his last assignment, Saxena led...  
09:16 AM, Nov 22, 2012

Mark Cavendish leaves Team Sky Paris: Spint ace Mark Cavendish is leaving Team Sky in order to fulfil his Tour de France ambitions after spending this year's race serving as a domestique for race winner Bradley Wiggins, the British team said on Thursday. Briton Cavendish, the 2011 world champion who has 23 Tour de France stage wins, will join Belgian team Omega Pharma-Quick Step for the 2013 season. Sky's Team Principal Dave Brailsford said Cavendish...  
11:52 PM, Oct 18, 2012

Andhra Pradesh: Pharma company unit gutted in fire Visakhapatnam: A pharmaceutical company unit was gutted when fire broke out at Ramky pharma city in Paradava mandal of the district, fire officials said. The equipment and chemicals of the Aputus Pharma company were completely gutted in the blaze which occurred late last night in a three-storeyed building, they said. Four fire tenders were pressed into service that took around five hours to control the flames. The mishap apparently occurred...  
04:32 PM, Oct 09, 2012

Shalini

Not Quite Miscellaneous |

I still remember meeting a young man of 26 who ate only once a day, to save money to pay for his mother's cancer drugs. ...
03:45 PM, Oct 04, 2012

Loopholes in pharma price policy, say drug experts New Delhi/Mumbai: The Cabinet is expected to take a decision on the proposed pharma price control policy on Thursday, which has been in discussion since 2007. But five years, two GoMs and a Supreme Court deadline later, drug experts say there are major loopholes in it. The question is whether the new policy will cut down drug prices or will medical bills go higher up in the long term. The...  
08:50 AM, Oct 04, 2012

GoM submits pharma pricing proposal to Cabinet New Delhi: A ministers panel, headed by Agriculture Minister Sharad Pawar, on Thursday finalised the pharma pricing policy under which 348 essential drugs will come under price control of the government. The Group of Ministers (GoM) will be sending their recommendations to the Cabinet within a week for approval to bring drugs in National List of Essential Medicines (NLEM), that have a total sales of around Rs 29,000 crore, which...  
10:41 AM, Sep 28, 2012

In India, gift-giving drives drug makers' marketing Mumbai: Sales representatives for Abbott Laboratories Inc's Indian subsidiaries know what it takes get a doctor to prescribe the drugs they market: a coffee maker, perhaps, or some cookware, or maybe a vacuum cleaner. These are among the many gifts for doctors listed in an Abbott sales-strategy guide for the second quarter of 2011, a copy of which was reviewed by Reuters. As laid out explicitly in the guide, doctors...  
06:29 PM, Sep 26, 2012

Govt approves eight foreign pharma investments New Delhi: India has approved eight foreign investments in drugmakers worth $333 million in total, signalling the finance ministry may be winning a battle to open up the country's fast-growing markets and giving a boost to global drugmakers hungry for growth. As a condition of its approval, however, the government said the foreign companies including US-based Pfizer and Germany's B-Braun would have to continue producing cheap drugs and maintain spending...  
03:20 AM, Sep 12, 2012

Five Indian firms among world's most innovative Washington: Five Indian companies including Larsen & Toubro, Hindustan Unilever and Infosys are ranked on Forbes magazine's list of "The World's Most Innovative Companies" topped by four US companies. Larsen & Toubro with an annual sales growth of 19 per cent is ranked ninth in the world followed by Hindustan Unilever (12) with 11.4 per cent. Infosys (19) comes third with 12.7 per cent growth thanks to what the US...  
07:30 PM, Sep 07, 2012

Legitimate Rape: Spoof ad attacks Akin's remark New Delhi: Todd Akin, a congressman since six years and the 2012 Republican Primary who will be contesting for the US senate, made an obnoxious remark to support his anti-abortion stance in a TV talk show. He said, "From what I understand from doctors, that's really rare, if it's a legitimate rape, the female body has ways to shut that whole thing down." First of all, how can a rape...  
01:53 PM, Aug 31, 2012

Ranbaxy launches generic tablets for diabetics in US New Delhi: Ranbaxy Laboratories on Friday said it has launched generic pioglitazone hydrochloride tablets used for treating diabetes in the American market under an agreement with Takeda Pharmaceuticals USA Inc. The company's wholly-owned subsidiary Ranbaxy Pharmaceuticals Inc has launched the drug following the expiry of patent held by Takeda Pharmaceutical. Ranbaxy is among the three companies, including Teva and Mylan, to have 180-days of marketing exclusivity for the drug in...  
05:34 PM, Aug 17, 2012